Research location

Tula

Russia

Published trials44

Site observations44

Linked trials published44

Page1 / 1

Research activity in Tula

Russia

CureCurrent currently publishes aggregate city-level research activity for this location: 44 trials and 44 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Tula

44 linked trials · page 1 of 1

Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry StudyNCT06521229 · 2024-06-27 · 1 site observation

A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast CancerNCT07386938 · 2024-08-09 · 1 site observation

ACTIVE_NOT_RECRUITING

PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of RussiaNCT06372431 · 2024-04-27 · 1 site observation

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in RussiaNCT05887011 · 2023-03-31 · 1 site observation

ACTIVE_NOT_RECRUITING

Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid ArthritisNCT06475508 · 2023-02-13 · 1 site observation

A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in RussiaNCT04943497 · 2021-07-27 · 1 site observation

Heart Failure Patients RegistryNCT04709263 · 2020-12-21 · 1 site observation

A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in RussiaNCT04315688 · 2020-03-30 · 1 site observation

The Use of TrIple Fixed-dose Combination in the Treatment of Arterial HypertensionNCT03722524 · 2018-10-01 · 1 site observation

A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerNCT03663569 · 2018-08-15 · 1 site observation

Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation

Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation

Non-Interventional Study PREVENTNCT02155998 · 2014-07-16 · 1 site observation

OVArian Cancer Non-Interventional Study - OVATARNCT02122588 · 2014-06-30 · 1 site observation

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®NCT01735175 · 2012-06-01 · 1 site observation

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast CancerNCT01561443 · 2012-05-01 · 1 site observation

An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid ArthritisNCT01664598 · 2012-05-01 · 1 site observation

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung CancerNCT01500720 · 2012-03-01 · 1 site observation

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the LungNCT01561456 · 2011-12-01 · 1 site observation

A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerNCT01358877 · 2011-11-08 · 1 site observation

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)NCT01350804 · 2011-09-01 · 1 site observation

Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerNCT01308580 · 2011-04-01 · 1 site observation

Asthma in ChildrenNCT01286532 · 2011-04-01 · 1 site observation

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and CarboplatinNCT01285609 · 2011-01-16 · 1 site observation

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung CancerNCT01244191 · 2011-01-11 · 1 site observation

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast CancerNCT01196052 · 2010-10-01 · 1 site observation

A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)NCT01120184 · 2010-07-31 · 1 site observation

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung CancerNCT01138163 · 2010-06-01 · 1 site observation

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung CancerNCT01160601 · 2010-06-01 · 1 site observation

Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)NCT01069835 · 2010-02-01 · 1 site observation

CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast CancerNCT01038804 · 2009-12-01 · 1 site observation

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation

A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisNCT01007435 · 2009-10-31 · 1 site observation

A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast CancerNCT00950300 · 2009-10-16 · 1 site observation

STRIDE - STimulating Immune Response In aDvanced brEast CancerNCT00925548 · 2009-09-01 · 1 site observation

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation

Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)NCT00928512 · 2009-07-01 · 1 site observation

Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid ArthritisNCT00867516 · 2008-10-01 · 1 site observation

Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical CareNCT01163916 · 2008-01-01 · 1 site observation

Study of Picoplatin Efficacy After RelapseNCT00465491 · 2007-04-01 · 1 site observation

An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core StudiesNCT00720798 · 2005-09-01 · 1 site observation

COX-2 Inhibitor Study In Patients With Rheumatoid ArthritisNCT00113308 · 2005-06-01 · 1 site observation

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00106574 · 2005-04-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.